{
    "abstract": "Epsilon toxin (Etx) is a \u03b2-pore-forming toxin produced by Clostridium perfringens toxinotypes B and D and plays a key role in the pathogenesis of enterotoxemia, a severe, often fatal disease of ruminants that causes significant economic losses to the farming industry worldwide. This study aimed to determine the potential of a site-directed mutant of Etx (Y30A-Y196A) to be exploited as a recombinant vaccine against enterotoxemia. Replacement of Y30 and Y196 with alanine generated a stable variant of Etx with significantly reduced cell binding and cytotoxic activities in MDCK.2 cells relative to wild type toxin (>430-fold increase in CT50) and Y30A-Y196A was inactive in mice after intraperitoneal administration of trypsin activated toxin at 1000\u00d7 the expected LD50 dose of trypsin activated wild type toxin. Moreover, polyclonal antibody raised in rabbits against Y30A-Y196A provided protection against wild type toxin in an in vitro neutralisation assay. These data suggest that Y30A-Y196A mutant could form the basis of an improved recombinant vaccine against enterotoxemia. \u00a9 2014 The Authors.",
    "author_highlights": [
        {
            "endOffset": 11807,
            "sentence": "Etx mutant Y30A-Y196A showed markedly reduced cytotoxicity towards MDCK.2 cells.",
            "startOffset": 11727
        },
        {
            "endOffset": 11876,
            "sentence": "Y30A-Y196A is inactive in mice after intraperitoneal administration.",
            "startOffset": 11808
        },
        {
            "endOffset": 11946,
            "sentence": "Y30A-Y196A is able to induce a specific antibody response in rabbits.",
            "startOffset": 11877
        },
        {
            "endOffset": 12025,
            "sentence": "Y30A-Y196A polyclonal antibody is able to induce protective immunity in vitro.",
            "startOffset": 11947
        },
        {
            "endOffset": 12105,
            "sentence": "Y30A-Y196A could form the basis of a recombinant vaccine against enterotoxemia.",
            "startOffset": 12026
        }
    ],
    "bib_entries": {
        "bib0005": {
            "authors": [
                {
                    "first": "Laetitia",
                    "initial": "L.",
                    "last": "Petit"
                },
                {
                    "first": "Maryse",
                    "initial": "M.",
                    "last": "Gibert"
                },
                {
                    "first": "Michel R.",
                    "initial": "M.R.",
                    "last": "Popoff"
                }
            ],
            "doi": "10.1016/S0966-842X(98)01430-9",
            "firstpage": "104",
            "issn": "0966842X",
            "lastpage": "110",
            "pmid": "10203838",
            "pub_year": 1999,
            "title": "Clostridium perfringens: Toxinotype and genotype",
            "volume": "7"
        },
        "bib0010": {
            "authors": [
                {
                    "first": "J. Glenn",
                    "initial": "J.G.",
                    "last": "Songer"
                }
            ],
            "firstpage": "216",
            "issn": "08938512",
            "lastpage": "234",
            "pmid": "8964036",
            "pub_year": 1996,
            "title": "Clostridial enteric diseases of domestic animals",
            "volume": "9"
        },
        "bib0015": null,
        "bib0020": {
            "authors": [
                {
                    "first": "Kareem Rashid",
                    "initial": "K.R.",
                    "last": "Rumah"
                },
                {
                    "first": "Jennifer",
                    "initial": "J.",
                    "last": "Linden"
                },
                {
                    "first": "Vincent A.",
                    "initial": "V.A.",
                    "last": "Fischetti"
                },
                {
                    "first": "Timothy",
                    "initial": "T.",
                    "last": "Vartanian"
                }
            ],
            "doi": "10.1371/journal.pone.0076359",
            "issn": "19326203",
            "pmid": "24146858",
            "pub_year": 2013,
            "title": "Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease",
            "volume": "8"
        },
        "bib0025": {
            "authors": [
                {
                    "first": "Francisco A.",
                    "initial": "F.A.",
                    "last": "Uzal"
                },
                {
                    "first": "J. Glenn",
                    "initial": "J.G.",
                    "last": "Songer"
                }
            ],
            "doi": "10.1177/104063870802000301",
            "firstpage": "253",
            "issn": "10406387",
            "lastpage": "265",
            "pmid": "18460610",
            "pub_year": 2008,
            "title": "Diagnosis of Clostridium perfringens intestinal infections in sheep and goats",
            "volume": "20"
        },
        "bib0030": {
            "authors": [
                {
                    "first": "J. W.",
                    "initial": "J.W.",
                    "last": "Finnie"
                }
            ],
            "doi": "10.1111/j.1751-0813.2003.tb11474.x",
            "firstpage": "219",
            "issn": "00050423",
            "lastpage": "221",
            "pmid": "15080445",
            "pub_year": 2003,
            "title": "Pathogenesis of brain damage produced in sheep by Clostridium perfringens type D epsilon toxin: A review",
            "volume": "81"
        },
        "bib0035": {
            "authors": [
                {
                    "first": "James L.",
                    "initial": "J.L.",
                    "last": "McDonel"
                }
            ],
            "doi": "10.1016/0163-7258(80)90031-5",
            "firstpage": "617",
            "issn": "01637258",
            "lastpage": "655",
            "pmid": "6255496",
            "pub_year": 1980,
            "title": "Clostridium perfringens toxins (type A, B, C, D, E)",
            "volume": "10"
        },
        "bib0040": {
            "authors": [
                {
                    "first": "Ajit S.",
                    "initial": "A.S.",
                    "last": "Bhown"
                },
                {
                    "first": "A. F.S.A.",
                    "initial": "A.F.S.A.",
                    "last": "Habeeb"
                }
            ],
            "doi": "10.1016/0006-291X(77)90506-X",
            "firstpage": "889",
            "issn": "0006291X",
            "lastpage": "896",
            "pmid": "199192",
            "pub_year": 1977,
            "title": "Structural studies on \u03b5-prototoxin of clostridium perfringens type D. Localization of the site of tryptic scission necessary for activation to \u03b5-toxin",
            "volume": "78"
        },
        "bib0045": {
            "authors": [
                {
                    "first": "F. U.",
                    "initial": "F.U.",
                    "last": "Jin"
                },
                {
                    "first": "Osamu",
                    "initial": "O.",
                    "last": "Matsushita"
                },
                {
                    "first": "Sej Ichi",
                    "initial": "S.I.",
                    "last": "Katayama"
                },
                {
                    "first": "Shengyong",
                    "initial": "S.",
                    "last": "Jin"
                },
                {
                    "first": "Chieko",
                    "initial": "C.",
                    "last": "Matsushita"
                },
                {
                    "first": "Junzaburo",
                    "initial": "J.",
                    "last": "Minami"
                },
                {
                    "first": "Akinobu",
                    "initial": "A.",
                    "last": "Okabe"
                }
            ],
            "firstpage": "230",
            "issn": "00199567",
            "lastpage": "237",
            "pmid": "8557345",
            "pub_year": 1996,
            "title": "Purification, characterization, and primary structure of Clostridium perfringens lambda-toxin, a thermolysin-like metalloprotease",
            "volume": "64"
        },
        "bib0050": {
            "authors": [
                {
                    "first": "Junzaburo",
                    "initial": "J.",
                    "last": "Minami"
                },
                {
                    "first": "Seiichi",
                    "initial": "S.",
                    "last": "Katayama"
                },
                {
                    "first": "Osamu",
                    "initial": "O.",
                    "last": "Matsushita"
                },
                {
                    "first": "Chieko",
                    "initial": "C.",
                    "last": "Matsushita"
                },
                {
                    "first": "Akinobu",
                    "initial": "A.",
                    "last": "Okabe"
                }
            ],
            "doi": "10.1111/j.1348-0421.1997.tb01888.x",
            "firstpage": "527",
            "issn": "03855600",
            "lastpage": "535",
            "pmid": "9272698",
            "pub_year": 1997,
            "title": "Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides",
            "volume": "41"
        },
        "bib0055": {
            "authors": [
                {
                    "first": "Dev",
                    "initial": "D.",
                    "last": "Chandran"
                },
                {
                    "first": "Sureddi Satyam",
                    "initial": "S.S.",
                    "last": "Naidu"
                },
                {
                    "first": "Parthasarathy",
                    "initial": "P.",
                    "last": "Sugumar"
                },
                {
                    "first": "Gudavalli Sudha",
                    "initial": "G.S.",
                    "last": "Rani"
                },
                {
                    "first": "Shahana Pallichera",
                    "initial": "S.P.",
                    "last": "Vijayan"
                },
                {
                    "first": "Deepika",
                    "initial": "D.",
                    "last": "Mathur"
                },
                {
                    "first": "Lalit C.",
                    "initial": "L.C.",
                    "last": "Garg"
                },
                {
                    "first": "Villuppanoor Alwar",
                    "initial": "V.A.",
                    "last": "Srinivasan"
                }
            ],
            "doi": "10.1128/CVI.00013-10",
            "firstpage": "1013",
            "issn": "15566811",
            "lastpage": "1016",
            "pmid": "20427629",
            "pub_year": 2010,
            "title": "Development of a recombinant epsilon toxoid vaccine against enterotoxemia and its use as a combination vaccine with live attenuated sheep pox virus against enterotoxemia and sheep pox",
            "volume": "17"
        },
        "bib0060": {
            "authors": [
                {
                    "first": "Francisco C.F.",
                    "initial": "F.C.F.",
                    "last": "Lobato"
                },
                {
                    "first": "Catarina G.R.D.",
                    "initial": "C.G.R.D.",
                    "last": "Lima"
                },
                {
                    "first": "Ronnie A.",
                    "initial": "R.A.",
                    "last": "Assis"
                },
                {
                    "first": "Prhiscylla S.",
                    "initial": "P.S.",
                    "last": "Pires"
                },
                {
                    "first": "Rodrigo O.S.",
                    "initial": "R.O.S.",
                    "last": "Silva"
                },
                {
                    "first": "Felipe M.",
                    "initial": "F.M.",
                    "last": "Salvarani"
                },
                {
                    "first": "Anderson O.",
                    "initial": "A.O.",
                    "last": "Carmo"
                },
                {
                    "first": "Christiane",
                    "initial": "C.",
                    "last": "Contigli"
                },
                {
                    "first": "Evanguedes",
                    "initial": "E.",
                    "last": "Kalapothakis"
                }
            ],
            "doi": "10.1016/j.vaccine.2010.07.046",
            "firstpage": "6125",
            "issn": "0264410X",
            "lastpage": "6127",
            "pmid": "20670910",
            "pub_year": 2010,
            "title": "Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants",
            "volume": "28"
        },
        "bib0065": {
            "authors": [
                {
                    "first": "G. L.",
                    "initial": "G.L.",
                    "last": "Stokka"
                },
                {
                    "first": "A. J.",
                    "initial": "A.J.",
                    "last": "Edwards"
                },
                {
                    "first": "M. F.",
                    "initial": "M.F.",
                    "last": "Spire"
                },
                {
                    "first": "R. T.",
                    "initial": "R.T.",
                    "last": "Brandt"
                },
                {
                    "first": "J. E.",
                    "initial": "J.E.",
                    "last": "Smith"
                }
            ],
            "firstpage": "415",
            "issn": "00031488",
            "lastpage": "419",
            "pmid": "8150699",
            "pub_year": 1994,
            "title": "Inflammatory response to clostridial vaccines in feedlot cattle",
            "volume": "204"
        },
        "bib0070": {
            "authors": [
                {
                    "first": "Monika",
                    "initial": "M.",
                    "last": "Bokori-Brown"
                },
                {
                    "first": "Maria C.",
                    "initial": "M.C.",
                    "last": "Kokkinidou"
                },
                {
                    "first": "Christos G.",
                    "initial": "C.G.",
                    "last": "Savva"
                },
                {
                    "first": "S\u00e9rgio P.Fernandes",
                    "initial": "S.P.F.",
                    "last": "Da Costa"
                },
                {
                    "first": "Claire E.",
                    "initial": "C.E.",
                    "last": "Naylor"
                },
                {
                    "first": "Ambrose R.",
                    "initial": "A.R.",
                    "last": "Cole"
                },
                {
                    "first": "David S.",
                    "initial": "D.S.",
                    "last": "Moss"
                },
                {
                    "first": "Ajit K.",
                    "initial": "A.K.",
                    "last": "Basak"
                },
                {
                    "first": "Richard W.",
                    "initial": "R.W.",
                    "last": "Titball"
                }
            ],
            "doi": "10.1002/pro.2250",
            "firstpage": "650",
            "issn": "09618368",
            "lastpage": "659",
            "pmid": "23504825",
            "pub_year": 2013,
            "title": "Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies",
            "volume": "22"
        },
        "bib0075": {
            "authors": [
                {
                    "first": "Susan E.",
                    "initial": "S.E.",
                    "last": "Ivie"
                },
                {
                    "first": "Mark S.",
                    "initial": "M.S.",
                    "last": "McClain"
                }
            ],
            "doi": "10.1021/bi300690a",
            "firstpage": "7588",
            "issn": "00062960",
            "lastpage": "7595",
            "pmid": "22938730",
            "pub_year": 2012,
            "title": "Identification of amino acids important for binding of Clostridium perfringens epsilon toxin to host cells and to HAVCR1",
            "volume": "51"
        },
        "bib0080": {
            "authors": [
                {
                    "first": "Jason J.",
                    "initial": "J.J.",
                    "last": "Lavinder"
                },
                {
                    "first": "Sanjay B.",
                    "initial": "S.B.",
                    "last": "Hari"
                },
                {
                    "first": "Brandon J.",
                    "initial": "B.J.",
                    "last": "Sullivan"
                },
                {
                    "first": "Thomas J.",
                    "initial": "T.J.",
                    "last": "Magliery"
                }
            ],
            "doi": "10.1021/ja8049063",
            "firstpage": "3794",
            "issn": "00027863",
            "lastpage": "3795",
            "pmid": "19292479",
            "pub_year": 2009,
            "title": "High-throughput thermal scanning: A general, rapid dye-binding thermal shift screen for protein engineering",
            "volume": "131"
        },
        "bib0085": {
            "authors": [
                {
                    "first": "Petra C.F.",
                    "initial": "P.C.F.",
                    "last": "Oyston"
                },
                {
                    "first": "Dean W.",
                    "initial": "D.W.",
                    "last": "Payne"
                },
                {
                    "first": "Helen L.",
                    "initial": "H.L.",
                    "last": "Havard"
                },
                {
                    "first": "E. Diane",
                    "initial": "E.D.",
                    "last": "Williamson"
                },
                {
                    "first": "Richard W.",
                    "initial": "R.W.",
                    "last": "Titball"
                }
            ],
            "doi": "10.1099/00221287-144-2-333",
            "firstpage": "333",
            "issn": "13500872",
            "lastpage": "341",
            "pmid": "9493371",
            "pub_year": 1998,
            "title": "Production of a non-toxic site-directed mutant of Clostridium perfringens \u03b5-toxin which induces protective immunity in mice",
            "volume": "144"
        },
        "bib0090": {
            "authors": [
                {
                    "first": "Qing",
                    "initial": "Q.",
                    "last": "Li"
                },
                {
                    "first": "Wenwen",
                    "initial": "W.",
                    "last": "Xin"
                },
                {
                    "first": "Shan",
                    "initial": "S.",
                    "last": "Gao"
                },
                {
                    "first": "Lin",
                    "initial": "L.",
                    "last": "Kang"
                },
                {
                    "first": "Jinglin",
                    "initial": "J.",
                    "last": "Wang"
                }
            ],
            "doi": "10.4161/hv.25649",
            "firstpage": "2386",
            "issn": "21645515",
            "lastpage": "2392",
            "pmid": "23835363",
            "pub_year": 2013,
            "title": "A low-toxic site-directed mutant of Clostridium perfringens \u03b5-toxin as a potential candidate vaccine against enterotoxemia",
            "volume": "9"
        },
        "bib0095": {
            "authors": [
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Hildebrand"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Pohl"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Bhakdi"
                }
            ],
            "firstpage": "17195",
            "issn": "00219258",
            "lastpage": "17200",
            "pmid": "1894613",
            "pub_year": 1991,
            "title": "Staphylococcus aureus \u03b1-toxin: Dual mechanism of binding to target cells",
            "volume": "266"
        },
        "bib0100": {
            "authors": [
                {
                    "first": "Osamu",
                    "initial": "O.",
                    "last": "Miyamoto"
                },
                {
                    "first": "Kazunori",
                    "initial": "K.",
                    "last": "Sumitani"
                },
                {
                    "first": "Takehiro",
                    "initial": "T.",
                    "last": "Nakamura"
                },
                {
                    "first": "Shin Ichi",
                    "initial": "S.I.",
                    "last": "Yamagami"
                },
                {
                    "first": "Shigeru",
                    "initial": "S.",
                    "last": "Miyata"
                },
                {
                    "first": "Toshifumi",
                    "initial": "T.",
                    "last": "Itano"
                },
                {
                    "first": "Tetsuro",
                    "initial": "T.",
                    "last": "Negi"
                },
                {
                    "first": "Akinobu",
                    "initial": "A.",
                    "last": "Okabe"
                }
            ],
            "doi": "10.1016/S0378-1097(00)00262-7",
            "firstpage": "109",
            "issn": "03781097",
            "lastpage": "113",
            "pmid": "10913875",
            "pub_year": 2000,
            "title": "Clostridium perfringens epsilon toxin causes excessive release of glutamate in the mouse hippocampus",
            "volume": "189"
        },
        "bib0105": {
            "authors": [
                {
                    "first": "Henry",
                    "initial": "H.",
                    "last": "Hirschberg"
                },
                {
                    "first": "Michelle J.",
                    "initial": "M.J.",
                    "last": "Zhang"
                },
                {
                    "first": "H. Michael",
                    "initial": "H.M.",
                    "last": "Gach"
                },
                {
                    "first": "Francisco A.",
                    "initial": "F.A.",
                    "last": "Uzal"
                },
                {
                    "first": "Qian",
                    "initial": "Q.",
                    "last": "Peng"
                },
                {
                    "first": "Chung Ho",
                    "initial": "C.H.",
                    "last": "Sun"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Chighvinadze"
                },
                {
                    "first": "Steen J.",
                    "initial": "S.J.",
                    "last": "Madsen"
                }
            ],
            "doi": "10.1007/s11060-009-9930-4",
            "firstpage": "317",
            "issn": "0167594X",
            "lastpage": "329",
            "pmid": "19506813",
            "pub_year": 2009,
            "title": "Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin",
            "volume": "95"
        },
        "bib0110": {
            "authors": [
                {
                    "first": "R. W.",
                    "initial": "R.W.",
                    "last": "Worthington"
                },
                {
                    "first": "M. S.G.",
                    "initial": "M.S.G.",
                    "last": "Mulders"
                }
            ],
            "firstpage": "549",
            "issn": "00199567",
            "lastpage": "551",
            "pmid": "200566",
            "pub_year": 1977,
            "title": "Physical changes in the epsilon prototoxin molecule of Clostridium perfringens during enzymatic activation",
            "volume": "18"
        },
        "bib0115": {
            "authors": [
                {
                    "first": "D. M.",
                    "initial": "D.M.",
                    "last": "Gill"
                }
            ],
            "doi": "10.1128/mmbr.46.1.86-94.1982",
            "firstpage": "86",
            "issn": "01460749",
            "lastpage": "94",
            "pmid": "6806598",
            "pub_year": 1982,
            "title": "Bacterial toxins: A table of lethal amounts",
            "volume": "46"
        }
    },
    "body_text": [
        {
            "endOffset": 19734,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "To compare the means of the On-Cell Western assay data, Two-Way ANOVA analysis followed by Dunnett's multiple comparisons test was carried out using the GraphPad Prism 6 software (GraphPad Software, La Jolla).",
            "startOffset": 19525,
            "title": "On-Cell Western assay"
        },
        {
            "endOffset": 27286,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "As shown in Fig. 5A, mice injected with either PBS or Y30A-Y196A survived for 24 h without showing any signs of intoxication, while mice injected with wild type toxin died within 50 min.",
            "startOffset": 27100,
            "title": "Toxicity of Y30A-Y196A in mice"
        },
        {
            "endOffset": 22826,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "The use of animals was conducted in accordance with the Animals (Scientific Procedures) Act (1986) and was performed with the approval of the on-site animal ethics committee.",
            "startOffset": 22652,
            "title": "Toxicity of trypsin activated Y30A-Y196A in mice"
        },
        {
            "endOffset": 20693,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "A horseradish-peroxidase-conjugated immunoglobulin antibody (IgG-HRP) was used to detect bound antibody and plates were developed by the addition of ABTS substrate.",
            "startOffset": 20529,
            "title": "Immunisation of rabbits with recombinant Y30A-Y196A prototoxin"
        },
        {
            "endOffset": 17450,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0070": {
                    "endOffset": 17449,
                    "startOffset": 17445
                }
            },
            "secId": "sec0015",
            "sentence": "Recombinant Y30A-Y196A was expressed, purified and its thermostability assessed as described previously [14].",
            "startOffset": 17341,
            "title": "Expression and purification of recombinant Etx mutant Y30A-Y196A"
        },
        {
            "endOffset": 15438,
            "parents": [],
            "refoffsets": {
                "bib0055": {
                    "endOffset": 15437,
                    "startOffset": 15430
                },
                "bib0060": {
                    "endOffset": 15437,
                    "startOffset": 15430
                }
            },
            "secId": "sec0005",
            "sentence": "These vaccines are based on either formaldehyde treated C. perfringens type D culture filtrate or formaldehyde-inactivated recombinant wild type toxin [11,12].",
            "startOffset": 15279,
            "title": "Introduction"
        },
        {
            "endOffset": 24850,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "As shown in Fig. 3, the fluorescent signal of MDCK.2 cells treated with Y30A-Y196A prototoxin was similar to that of cells treated with PBS only.",
            "startOffset": 24705,
            "title": "Binding of Y30A-Y196A prototoxin to MDCK.2 and ACHN cells"
        },
        {
            "endOffset": 26516,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "Therefore, we next tested the toxicity of trypsin activated Y30A-Y196A after intraperitoneal administration in groups of six mice.",
            "startOffset": 26386,
            "title": "Toxicity of Y30A-Y196A in mice"
        },
        {
            "endOffset": 25720,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "To test the ability of the polyclonal antiserum raised in rabbits against Y30A-Y196A prototoxin to neutralise the cytotoxic activity of wild type Etx in MDCK.2 cells, we used the in vitro neutralisation assay as described in Materials and Methods.",
            "startOffset": 25473,
            "title": "Y30A-Y196A polyclonal antiserum raised in rabbits is able to induce protective immunity in vitro"
        },
        {
            "endOffset": 31189,
            "parents": [],
            "refoffsets": {
                "bib0110": {
                    "endOffset": 31084,
                    "startOffset": 31080
                }
            },
            "secId": "sec0085",
            "sentence": "Taking into account that Etx prototoxin is >1000-fold less active compared to activated toxin [22], intraperitoneal injection of activated Etx would yield a LD50 of approximately 40 ng/kg of body weight.",
            "startOffset": 30986,
            "title": "Discussion"
        },
        {
            "endOffset": 14112,
            "parents": [],
            "refoffsets": {
                "bib0020": {
                    "endOffset": 14111,
                    "startOffset": 14108
                }
            },
            "secId": "sec0005",
            "sentence": "More recently, toxinotype B has been detected in a human with a clinical presentation of multiple sclerosis, providing clues for environment triggers of the disease [4].",
            "startOffset": 13943,
            "title": "Introduction"
        },
        {
            "endOffset": 30291,
            "parents": [],
            "secId": "sec0085",
            "sentence": "Due to the differential activity of mutant Y30A-Y196A in MDCK.2 and ACHN cells, we assessed the safety of this variant for immunisation by intraperitoneal administration of trypsin activated Y30A-Y196A to mice.",
            "startOffset": 30081,
            "title": "Discussion"
        },
        {
            "endOffset": 21054,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "Trypsin-activated wild type Etx at a dose of 1\u00d7 CT50 was incubated for 1 h at room temperature with serial dilutions of either Y30A-Y196A rabbit polyclonal antiserum or with a negative control antibody.",
            "startOffset": 20852,
            "title": "In vitro neutralisation assay"
        },
        {
            "endOffset": 32949,
            "parents": [],
            "secId": "sec0090",
            "sentence": "SPFC, CGS, CEN and ARC helped with experiments and interpreted the data.",
            "startOffset": 32877,
            "title": "Authors\u2019 contributions"
        },
        {
            "endOffset": 19229,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "Bound prototoxin was detected with mouse anti-Etx monoclonal Bio355 antibody (Bio-X Diagnostics S.P.R.L, Belgium) and IRDye 800CW goat anti-mouse IgG (H + L) antibody (LI-COR Biosciences, Lincoln, USA) at 1:500 dilution each.",
            "startOffset": 19004,
            "title": "On-Cell Western assay"
        },
        {
            "endOffset": 32350,
            "parents": [],
            "secId": "sec0085",
            "sentence": "We also showed that polyclonal antibody raised against Y30A-Y196A provides protection against wild type toxin in an in vitro neutralisation assay.",
            "startOffset": 32204,
            "title": "Discussion"
        },
        {
            "endOffset": 19524,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "The binding activity of the mutant prototoxin was expressed as the percentage of fluorescence intensity relative to wild type prototoxin.",
            "startOffset": 19387,
            "title": "On-Cell Western assay"
        },
        {
            "endOffset": 20188,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "The remainder immunisations used Freund's incomplete adjuvant.",
            "startOffset": 20126,
            "title": "Immunisation of rabbits with recombinant Y30A-Y196A prototoxin"
        },
        {
            "endOffset": 26906,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "Mice injected with 1\u00d7 and 10\u00d7 LD50 of wild type toxin survived for 24 h without showing any signs of intoxication, whereas a dose of 100\u00d7 LD50 resulted in death within 180 min post-injection and a dose of 1000\u00d7 LD50 resulted in death by 45.5 min post-injection.",
            "startOffset": 26645,
            "title": "Toxicity of Y30A-Y196A in mice"
        },
        {
            "endOffset": 32714,
            "parents": [],
            "secId": "sec0085",
            "sentence": "Further studies are needed to determine whether Y30A-Y196A is able to induce protection against experimental enterotoxemia in sheep.",
            "startOffset": 32582,
            "title": "Discussion"
        },
        {
            "endOffset": 18593,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0070": {
                    "endOffset": 18592,
                    "startOffset": 18588
                }
            },
            "secId": "sec0030",
            "sentence": "The cytotoxic activity of trypsin-activated toxin toward MDCK.2 and ACHN cells was determined by measuring the amount of lactate dehydrogenase (LDH) released from the cytosol of lysed cells into the cell culture medium using the CytoTox 96 nonradioactive cytotoxicity assay kit (Promega UK, Southampton, UK) as described previously [14].",
            "startOffset": 18256,
            "title": "Cytotoxicity assay"
        },
        {
            "endOffset": 14656,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Overproduction of Etx causes increased intestinal permeability, facilitating entry of the toxin into the bloodstream and its spread into various organs, including the brain, lungs and kidneys.",
            "startOffset": 14464,
            "title": "Introduction"
        },
        {
            "endOffset": 22176,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "The challenged animals were monitored continuously for the first hour post challenge, at hourly intervals until 6 h post challenge and then at further 6 h intervals.",
            "startOffset": 22011,
            "title": "Toxicity of trypsin activated Y30A-Y196A in mice"
        },
        {
            "endOffset": 29937,
            "parents": [],
            "refoffsets": {
                "bib0070": {
                    "endOffset": 29936,
                    "startOffset": 29932
                }
            },
            "secId": "sec0085",
            "sentence": "In contrast, the double mutant Y30A-Y196A showed no reduction in cytotoxic activity in ACHN cells relative to wild type toxin, further supporting the findings of our previous study that surface exposed tyrosine residues in domain I do not mediate cytotoxicity of Etx in ACHN cells [14].",
            "startOffset": 29651,
            "title": "Discussion"
        },
        {
            "endOffset": 24510,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib0085": {
                    "endOffset": 24458,
                    "startOffset": 24454
                }
            },
            "secId": "sec0065",
            "sentence": "No LDH release could be measured when MDCK.2 or ACHN cells were treated with trypsin activated Etx mutant H106P [17], even at the maximum concentration of 10 \u03bcM tested.",
            "startOffset": 24342,
            "title": "Cytotoxic activity of trypsin activated Y30A-Y196A toward MDCK.2 and ACHN cells"
        },
        {
            "endOffset": 24341,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "In contrast, the results of our cytotoxicity assay in ACHN cells revealed that the cytotoxic activity of trypsin activated Y30A-Y196A was equivalent to that of wild type toxin (Fig. 2B).",
            "startOffset": 24155,
            "title": "Cytotoxic activity of trypsin activated Y30A-Y196A toward MDCK.2 and ACHN cells"
        },
        {
            "endOffset": 21321,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "Data were expressed relative to the LDH released from cells treated with toxin only.",
            "startOffset": 21237,
            "title": "In vitro neutralisation assay"
        },
        {
            "endOffset": 14463,
            "parents": [],
            "refoffsets": {
                "bib0010": {
                    "endOffset": 14462,
                    "startOffset": 14457
                },
                "bib0025": {
                    "endOffset": 14462,
                    "startOffset": 14457
                }
            },
            "secId": "sec0005",
            "sentence": "The most important factor in initiating disease is the disruption of the microbial balance in the gut due to overeating carbohydrate rich food, which causes proliferation of C. perfringens and consequent overproduction of the toxin [2,5].",
            "startOffset": 14225,
            "title": "Introduction"
        },
        {
            "endOffset": 21968,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "The amounts of trypsin-activated toxins used in this study are listed in Supplementary Table 1.",
            "startOffset": 21873,
            "title": "Toxicity of trypsin activated Y30A-Y196A in mice"
        },
        {
            "endOffset": 20528,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "In brief, a two-fold dilution series of each serum (ranging from 1:100 to 1:204,800) was prepared and added to a 96-well plate coated with recombinant Y30A-Y196A prototoxin.",
            "startOffset": 20355,
            "title": "Immunisation of rabbits with recombinant Y30A-Y196A prototoxin"
        },
        {
            "endOffset": 20125,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "For the initial immunisation Freund's complete adjuvant was used.",
            "startOffset": 20060,
            "title": "Immunisation of rabbits with recombinant Y30A-Y196A prototoxin"
        },
        {
            "endOffset": 33011,
            "parents": [],
            "secId": "sec0090",
            "sentence": "RT, DSM and AKB designed research and revised the manuscript.",
            "startOffset": 32950,
            "title": "Authors\u2019 contributions"
        },
        {
            "endOffset": 21872,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "Groups of six female BALB/c mice were challenged by the intraperitoneal route with a dose of trypsin-activated wild type toxin corresponding to 1\u00d7, 10\u00d7, 100\u00d7 or 1000\u00d7 the expected LD50 dose of wild type toxin in phosphate buffered saline, pH 7.2 (PBS) (2 ng, 20 ng, 200 ng or 2 \u03bcg/mouse, respectively, in 100 \u03bcl volume) or with a dose of trypsin-activated Y30A-Y196A corresponding to 10\u00d7 or 1000\u00d7 the expected LD50 dose of wild type toxin in PBS (20 ng or 2 \u03bcg/mouse, respectively, in 100 \u03bcl volume).",
            "startOffset": 21372,
            "title": "Toxicity of trypsin activated Y30A-Y196A in mice"
        },
        {
            "endOffset": 27064,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "To test the toxicity of Y30A-Y196A in vivo, mice were injected with trypsin activated Y30A-Y196A at a dose of 1000\u00d7 LD50 of trypsin-activated wild type toxin.",
            "startOffset": 26906,
            "title": "Toxicity of Y30A-Y196A in mice"
        },
        {
            "endOffset": 24154,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "The average dose of Y30A-Y196A required to kill 50% of MDCK.2 cells was determined to be 1.49 \u03bcM, corresponding to an approximately 430-fold reduction in cytotoxic activity relative to wild type Etx with a CT50 value of 3.47 nM (Fig. 2A).",
            "startOffset": 23916,
            "title": "Cytotoxic activity of trypsin activated Y30A-Y196A toward MDCK.2 and ACHN cells"
        },
        {
            "endOffset": 32203,
            "parents": [],
            "secId": "sec0085",
            "sentence": "We showed that Y30A-Y196A is inactive in mice after intraperitoneal administration of up to 1000\u00d7 the expected LD50 dose of wild type toxin, mirroring our in vitro cytotoxicity data in MDCK.2 cells.",
            "startOffset": 32005,
            "title": "Discussion"
        },
        {
            "endOffset": 29049,
            "parents": [],
            "secId": "sec0085",
            "sentence": "Simultaneous replacement of Y30 and Y196 with alanine generated a stable variant of Etx that showed significantly reduced cell binding and cytotoxic activities in MDCK.2 cells but not in ACHN cells.",
            "startOffset": 28851,
            "title": "Discussion"
        },
        {
            "endOffset": 18857,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "All experiments were performed in triplicate with three technical replicates each.",
            "startOffset": 18775,
            "title": "Cytotoxicity assay"
        },
        {
            "endOffset": 18123,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "The culture medium was replaced every 2\u20133 days.",
            "startOffset": 18076,
            "title": "Cell culture"
        },
        {
            "endOffset": 33063,
            "parents": [],
            "secId": "sec0090",
            "sentence": "All authors read and approved the final manuscript.",
            "startOffset": 33012,
            "title": "Authors\u2019 contributions"
        },
        {
            "endOffset": 30081,
            "parents": [],
            "refoffsets": {
                "bib0095": {
                    "endOffset": 30080,
                    "startOffset": 30076
                }
            },
            "secId": "sec0085",
            "sentence": "These data suggest that Etx may have a dual mechanism of binding to target cells, similar to Staphylococcus aureus alpha hemolysin (\u03b1-HL) [19].",
            "startOffset": 29938,
            "title": "Discussion"
        },
        {
            "endOffset": 13501,
            "parents": [],
            "refoffsets": {
                "bib0005": {
                    "endOffset": 13500,
                    "startOffset": 13497
                }
            },
            "secId": "sec0005",
            "sentence": "Clostridium perfringens is a Gram positive, anaerobe, spore forming bacterium that is classified into five toxinotypes based on production of the four typing toxins (\u03b1-, \u03b2-, \u025b-, and \u03b9-toxins) [1].",
            "startOffset": 13305,
            "title": "Introduction"
        },
        {
            "endOffset": 16259,
            "parents": [],
            "refoffsets": {
                "bib0070": {
                    "endOffset": 16258,
                    "startOffset": 16251
                },
                "bib0075": {
                    "endOffset": 16258,
                    "startOffset": 16251
                }
            },
            "secId": "sec0005",
            "sentence": "Amino acid residues Y30 and Y196 have previously been identified to play key roles in cell binding and thus, cytotoxicity of Etx [14,15].",
            "startOffset": 16122,
            "title": "Introduction"
        },
        {
            "endOffset": 32876,
            "parents": [],
            "secId": "sec0090",
            "sentence": "CAH carried out and CV assisted with the in vivo toxicity assay.",
            "startOffset": 32812,
            "title": "Authors\u2019 contributions"
        },
        {
            "endOffset": 30985,
            "parents": [],
            "refoffsets": {
                "bib0105": {
                    "endOffset": 30984,
                    "startOffset": 30980
                }
            },
            "secId": "sec0085",
            "sentence": "Intraperitoneal injection of Etx prototoxin into Fisher rats with an average weight of 350 g produced a LD50 of 14 \u03bcg/animal or 40 \u03bcg/kg of body weight [21].",
            "startOffset": 30828,
            "title": "Discussion"
        },
        {
            "endOffset": 27880,
            "parents": [],
            "refoffsets": {
                "bib0085": {
                    "endOffset": 27879,
                    "startOffset": 27875
                }
            },
            "secId": "sec0085",
            "sentence": "The site-directed mutant H106P with no activity has been shown to be non-toxic to mice after intravenous administration of periplasmic extracts from Escherichia coli [17].",
            "startOffset": 27709,
            "title": "Discussion"
        },
        {
            "endOffset": 26385,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "Our in vitro toxicity data revealed that trypsin activated Y30A-Y196A has differential cytototoxic activity toward MDCK.2 and ACHN cells, showing markedly reduced cytotoxicity in MDCK.2 cells but equivalent cytotoxic activity to wild type toxin in ACHN cells.",
            "startOffset": 26126,
            "title": "Toxicity of Y30A-Y196A in mice"
        },
        {
            "endOffset": 25473,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "The mean IgG titre against purified Y30A-Y196A prototoxin was measured by indirect ELISA on day 107 of the immunisation schedule and determined to be 1:16,000 (Immune Systems Ltd., UK), indicating that immunisation of rabbits with Y30A-Y196A prototoxin induced a specific antibody response.",
            "startOffset": 25183,
            "title": "Y30A-Y196A polyclonal antiserum raised in rabbits is able to induce protective immunity in vitro"
        },
        {
            "endOffset": 22532,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "Details of the scoring system are described in Supplementary Table 2.",
            "startOffset": 22463,
            "title": "Toxicity of trypsin activated Y30A-Y196A in mice"
        },
        {
            "endOffset": 23718,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib0070": {
                    "endOffset": 23717,
                    "startOffset": 23713
                }
            },
            "secId": "sec0060",
            "sentence": "The H149A mutation has previously been shown not to have an effect on the prototoxin tertiary structure [14].",
            "startOffset": 23609,
            "title": "Identification of recombinant Y30A-Y196A as a vaccine candidate"
        },
        {
            "endOffset": 16122,
            "parents": [],
            "secId": "sec0005",
            "sentence": "One approach to solving this problem is to develop recombinant vaccines based on site-directed mutants with markedly reduced toxicity.",
            "startOffset": 15988,
            "title": "Introduction"
        },
        {
            "endOffset": 20059,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "A group of three New Zealand White rabbits were immunised subcutaneously eight times on days 0, 14, 28, 42, 56, 70, 84 and 98 with a dose of 200 \u03bcg purified recombinant Y30A-Y196A prototoxin in phosphate buffered saline, pH 7.2 (PBS) (Immune Systems Ltd., UK).",
            "startOffset": 19799,
            "title": "Immunisation of rabbits with recombinant Y30A-Y196A prototoxin"
        },
        {
            "endOffset": 24704,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "We also evaluated the effect of Y30A-Y196A prototoxin on its ability to bind to MDCK.2 and ACHN cells using the On-Cell Western assay.",
            "startOffset": 24570,
            "title": "Binding of Y30A-Y196A prototoxin to MDCK.2 and ACHN cells"
        },
        {
            "endOffset": 19003,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0070": {
                    "endOffset": 19002,
                    "startOffset": 18998
                }
            },
            "secId": "sec0035",
            "sentence": "To measure binding of prototoxin to MDCK.2 and ACHN cells the On-Cell Western assay was used as described previously [14].",
            "startOffset": 18881,
            "title": "On-Cell Western assay"
        },
        {
            "endOffset": 20272,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "Pre-immune sera were collected on day 0 and harvest bleed was collected on day 107.",
            "startOffset": 20189,
            "title": "Immunisation of rabbits with recombinant Y30A-Y196A prototoxin"
        },
        {
            "endOffset": 29650,
            "parents": [],
            "secId": "sec0085",
            "sentence": "Mutant Y30A-Y196A in this study showed 430-fold reduction in cytotoxic activity relative to wild type Etx in MDCK.2 cells, suggesting that mutations Y30A and Y196A have a cumulative effect on reducing the ability of Etx to lyse MDCK.2 cells.",
            "startOffset": 29409,
            "title": "Discussion"
        },
        {
            "endOffset": 17341,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Recombinant P-Etx with Y30A and Y196A mutations is termed Y30A-Y196A.",
            "startOffset": 17272,
            "title": "Expression and purification of recombinant Etx mutant Y30A-Y196A"
        },
        {
            "endOffset": 23915,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "The cytotoxic activity of trypsin activated Y30A-Y196A toward MDCK.2 and ACHN cells were measured by the LDH assay.",
            "startOffset": 23800,
            "title": "Cytotoxic activity of trypsin activated Y30A-Y196A toward MDCK.2 and ACHN cells"
        },
        {
            "endOffset": 32005,
            "parents": [],
            "secId": "sec0085",
            "sentence": "Therefore, our working assumption was that the LD50 value of trypsin activated wild type Etx after intraperitoneal administration to mice is 100 ng/kg of body weight or approximately 2 ng/mouse with an average weight of 20 g. Mice injected with 2 ng or 20 ng trypsin activated wild type Etx by the intraperitoneal route survived for 24 h without showing any signs of intoxication, whereas a dose of 200 ng trypsin activated wild type Etx resulted in death within 180 min post-injection, suggesting that the LD50 value of trypsin activated wild type Etx administered to mice by the intraperitoneal route is between 20 ng and 200 ng/mouse, extrapolated to 1\u201310 \u03bcg/kg of body weight.",
            "startOffset": 31325,
            "title": "Discussion"
        },
        {
            "endOffset": 27099,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "Control animals received PBS only.",
            "startOffset": 27065,
            "title": "Toxicity of Y30A-Y196A in mice"
        },
        {
            "endOffset": 28296,
            "parents": [],
            "refoffsets": {
                "bib0090": {
                    "endOffset": 28295,
                    "startOffset": 28291
                }
            },
            "secId": "sec0085",
            "sentence": "The low toxicity site-directed Etx mutant F199E has recently been shown to protect immunised mice against a 100\u00d7 LD50 dose of recombinant wild type Etx toxin [18].",
            "startOffset": 28133,
            "title": "Discussion"
        },
        {
            "endOffset": 17208,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Mutations Y30A and Y196A (amino acid numbering corresponds to prototoxin without the 13 amino acids N-terminal peptide sequence) were introduced into the gene encoding epsilon prototoxin (P-Etx) using the QuickChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies, Inc.",
            "startOffset": 16924,
            "title": "Expression and purification of recombinant Etx mutant Y30A-Y196A"
        },
        {
            "endOffset": 26644,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "First, we determined the toxicity of trypsin activated wild type Etx after intraperitoneal administration in groups of six mice.",
            "startOffset": 26516,
            "title": "Toxicity of Y30A-Y196A in mice"
        },
        {
            "endOffset": 14225,
            "parents": [],
            "refoffsets": {
                "bib0010": {
                    "endOffset": 14224,
                    "startOffset": 14219
                },
                "bib0015": {
                    "endOffset": 14224,
                    "startOffset": 14219
                }
            },
            "secId": "sec0005",
            "sentence": "C. perfringens toxinotype D affects mainly sheep and lambs but also causes infections in goats and calves [2,3].",
            "startOffset": 14113,
            "title": "Introduction"
        },
        {
            "endOffset": 23254,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "Etx mutant Y30A-Y196A was expressed and purified as described in Materials and Methods.",
            "startOffset": 23167,
            "title": "Identification of recombinant Y30A-Y196A as a vaccine candidate"
        },
        {
            "endOffset": 26093,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "In contrast, the negative control antibody did not inhibit Etx-induced cytotoxicity at any of the doses tested.",
            "startOffset": 25982,
            "title": "Y30A-Y196A polyclonal antiserum raised in rabbits is able to induce protective immunity in vitro"
        },
        {
            "endOffset": 27451,
            "parents": [],
            "refoffsets": {
                "bib0070": {
                    "endOffset": 27450,
                    "startOffset": 27446
                }
            },
            "secId": "sec0085",
            "sentence": "Recently, we have determined the roles of surface exposed tyrosine residues in domain I of Etx mediating binding and toxicity of Etx to target cells [14].",
            "startOffset": 27297,
            "title": "Discussion"
        },
        {
            "endOffset": 30551,
            "parents": [],
            "secId": "sec0085",
            "sentence": "Thus, this study also determined the toxicity of trypsin activated wild type Etx after intraperitoneal administration in groups of six mice.",
            "startOffset": 30411,
            "title": "Discussion"
        },
        {
            "endOffset": 15884,
            "parents": [],
            "refoffsets": {
                "bib0060": {
                    "endOffset": 15706,
                    "startOffset": 15702
                },
                "bib0065": {
                    "endOffset": 15798,
                    "startOffset": 15794
                }
            },
            "secId": "sec0005",
            "sentence": "These vaccine preparations have several disadvantages: (1) complete removal of free formaldehyde is required to avoid possible toxic side effects, (2) toxoiding using formaldehyde can show considerable batch to batch variation in immunogenicity of these vaccines [12], (3) inflammatory responses following vaccination can lead to reduced feed consumption [13] and (4) reversion to toxicity may occur in incompletely inactivated bacterial toxins.",
            "startOffset": 15439,
            "title": "Introduction"
        },
        {
            "endOffset": 28851,
            "parents": [],
            "secId": "sec0085",
            "sentence": "Therefore, the use of recombinant Etx vaccines derived from low toxicity site-directed mutants with two mutations, such as the Y30A-Y196A mutant developed in this study, would greatly reduce the risk of reversion to full activity, making Y30A-Y196A an ideal recombinant vaccine candidate.",
            "startOffset": 28563,
            "title": "Discussion"
        },
        {
            "endOffset": 28132,
            "parents": [],
            "refoffsets": {
                "bib0085": {
                    "endOffset": 28131,
                    "startOffset": 28127
                }
            },
            "secId": "sec0085",
            "sentence": "Moreover, immunisation of mice with H106P mutant resulted in the induction of a specific antibody response and immunised mice were protected against a subsequent challenge of 1000\u00d7 LD50 dose of wild type Etx administered by the intravenous route [17].",
            "startOffset": 27881,
            "title": "Discussion"
        },
        {
            "endOffset": 15987,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Therefore, there is a need to identify Etx variants with reduced toxicity relative to wild type toxin.",
            "startOffset": 15885,
            "title": "Introduction"
        },
        {
            "endOffset": 28562,
            "parents": [],
            "secId": "sec0085",
            "sentence": "While these Etx mutants are promising vaccine candidates against enterotoxemia, recombinant Etx vaccines derived from site-directed mutants with a single mutation risk reversion to full activity in a DNA based vaccine or in a live vaccine vector such as Salmonella.",
            "startOffset": 28297,
            "title": "Discussion"
        },
        {
            "endOffset": 32581,
            "parents": [],
            "secId": "sec0085",
            "sentence": "In conclusion, this study showed that recombinant Etx mutant Y30A-Y196A is non-toxic to mice, demonstrating the potential of Y30A-Y196A mutant to form the basis of an improved recombinant vaccine against enterotoxemia in ruminants.",
            "startOffset": 32350,
            "title": "Discussion"
        },
        {
            "endOffset": 20354,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "Post-inject antibodies were detected by indirect ELISA (Immune Systems Ltd., UK).",
            "startOffset": 20273,
            "title": "Immunisation of rabbits with recombinant Y30A-Y196A prototoxin"
        },
        {
            "endOffset": 17271,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Santa Clara, US) according to the manufacturer's instructions.",
            "startOffset": 17209,
            "title": "Expression and purification of recombinant Etx mutant Y30A-Y196A"
        },
        {
            "endOffset": 23608,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib0080": {
                    "endOffset": 23413,
                    "startOffset": 23409
                }
            },
            "secId": "sec0060",
            "sentence": "Thermal stability assay [16] revealed that the melting temperature (Tm) of Y30A-Y196A was similar to that of Etx with H149A mutation, providing further evidence that the double tyrosine mutant is folded correctly (Fig. 1C).",
            "startOffset": 23385,
            "title": "Identification of recombinant Y30A-Y196A as a vaccine candidate"
        },
        {
            "endOffset": 20820,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "Titres were calculated by measuring the dilution point where the absorbance at OD405nm dropped below 0.2 (4 times background).",
            "startOffset": 20694,
            "title": "Immunisation of rabbits with recombinant Y30A-Y196A prototoxin"
        },
        {
            "endOffset": 19386,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "To quantify the amount of fluorescent signal, plates were imaged at 800 nm using the Odyssey CLx infrared imaging system (LI-COR Biosciences, Lincoln, USA).",
            "startOffset": 19230,
            "title": "On-Cell Western assay"
        },
        {
            "endOffset": 21236,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "The toxin-antibody mixtures were added to MDCK.2 cells plated in a 96-well plate and incubated at 37 \u00b0C for 3 h before cytotoxicity was measured by the LDH assay as described above.",
            "startOffset": 21055,
            "title": "In vitro neutralisation assay"
        },
        {
            "endOffset": 15278,
            "parents": [],
            "secId": "sec0005",
            "sentence": "To prevent Etx-induced enterotoxemia in domesticated livestock, a number of commercial vaccines are available that have been used extensively over the past decades.",
            "startOffset": 15114,
            "title": "Introduction"
        },
        {
            "endOffset": 16924,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0070": {
                    "endOffset": 16923,
                    "startOffset": 16919
                }
            },
            "secId": "sec0015",
            "sentence": "The gene encoding epsilon prototoxin, etxD, from C. perfringens Type D strain NCTC 8346 was cloned into the expression vector pET-26b(+) (Merck, Darmstadt, Germany) with a N-terminal PelB leader peptide in place of the 13 amino acids N-terminal peptide sequence (residues KEISNTVSNEMSK) and with a C-terminal polyhistidine (6\u00d7 His) tag as described previously [14].",
            "startOffset": 16559,
            "title": "Expression and purification of recombinant Etx mutant Y30A-Y196A"
        },
        {
            "endOffset": 30827,
            "parents": [],
            "secId": "sec0085",
            "sentence": "There is less data on the LD50 dose of wild type Etx when given by the intraperitoneal route to mice.",
            "startOffset": 30726,
            "title": "Discussion"
        },
        {
            "endOffset": 18075,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "MDCK.2 cells (ATCC-LGC Standards, Teddington, UK) and ACHN cells (ECACC, Salisbury, UK) were routinely cultured in Eagle's Minimum Essential Medium (EMEM; ATCC-LGC Standards, Teddington, UK) supplemented with 10% Foetal Bovine Serum Gold (PAA, Pasching, Austria) at 37 \u00b0C in a humidified atmosphere of 95% air/5% CO2.",
            "startOffset": 17758,
            "title": "Cell culture"
        },
        {
            "endOffset": 27708,
            "parents": [],
            "refoffsets": {
                "bib0085": {
                    "endOffset": 27707,
                    "startOffset": 27700
                },
                "bib0090": {
                    "endOffset": 27707,
                    "startOffset": 27700
                }
            },
            "secId": "sec0085",
            "sentence": "Site-directed mutants of Etx with markedly reduced toxicity have previously been produced [17,18].",
            "startOffset": 27610,
            "title": "Discussion"
        },
        {
            "endOffset": 18235,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Cells were routinely detached by incubation in trypsin/EDTA and split as appropriate (typically 1:6 dilutions).",
            "startOffset": 18124,
            "title": "Cell culture"
        },
        {
            "endOffset": 23384,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "Purified recombinant Y30A-Y196A prototoxin had an apparent molecular weight of \u223c37 kDa as detected by SDS-PAGE (Fig. 1B, lane 2).",
            "startOffset": 23255,
            "title": "Identification of recombinant Y30A-Y196A as a vaccine candidate"
        },
        {
            "endOffset": 14929,
            "parents": [],
            "secId": "sec0005",
            "sentence": "For full activity of the toxin, proteolytic processing is required, with carboxy-terminal and amino-terminal peptides removed.",
            "startOffset": 14803,
            "title": "Introduction"
        },
        {
            "endOffset": 24996,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "In contrast, ACHN cells treated with Y30A-Y196A prototoxin showed fluorescence equivalent to that of cells treated with wild type toxin (Fig. 3).",
            "startOffset": 24851,
            "title": "Binding of Y30A-Y196A prototoxin to MDCK.2 and ACHN cells"
        },
        {
            "endOffset": 25981,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "As shown in Fig. 4, the polyclonal antiserum raised against Y30A-Y196A prototoxin was able to protect MDCK.2 cells against wild type Etx-induced cytotoxicity in a dose-dependent manner (up to dilution 26, which corresponds to 0.2 \u03bcg/ml antibody concentration).",
            "startOffset": 25721,
            "title": "Y30A-Y196A polyclonal antiserum raised in rabbits is able to induce protective immunity in vitro"
        },
        {
            "endOffset": 18774,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "The toxin dose required to kill 50% of the cell monolayer (CT50) was determined by nonlinear regression analysis using GraphPad Prism 6 software (GraphPad Software, La Jolla, USA).",
            "startOffset": 18594,
            "title": "Cytotoxicity assay"
        },
        {
            "endOffset": 13942,
            "parents": [],
            "refoffsets": {
                "bib0010": {
                    "endOffset": 13941,
                    "startOffset": 13936
                },
                "bib0015": {
                    "endOffset": 13941,
                    "startOffset": 13936
                }
            },
            "secId": "sec0005",
            "sentence": "C. perfringens toxinotype B is the etiologic agent of dysentery in newborn lambs and haemorrhagic enteritis and enterotoxemia in goats, calves and foals [2,3].",
            "startOffset": 13783,
            "title": "Introduction"
        },
        {
            "endOffset": 33133,
            "parents": [],
            "secId": "sec0095",
            "sentence": "The authors have no competing interests.",
            "startOffset": 33093,
            "title": "Conflict of interest statement"
        },
        {
            "endOffset": 22462,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "The challenged animals were monitored continuously and scored according to severity of clinical signs and neurological effects on a scale of 0\u20133, with 0 indicating no change and values between 1 and 3 indicating increasing severity.",
            "startOffset": 22230,
            "title": "Toxicity of trypsin activated Y30A-Y196A in mice"
        },
        {
            "endOffset": 17743,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0070": {
                    "endOffset": 17742,
                    "startOffset": 17738
                }
            },
            "secId": "sec0020",
            "sentence": "Purified recombinant Etx prototoxin was activated with trypsin, TPCK treated from bovine pancreas (Sigma-Aldrich Company Ltd., Gillingham, UK) for 1 h at room temperature and removal of the C-terminal peptide sequence was assessed by SDS-PAGE as described previously [14].",
            "startOffset": 17471,
            "title": "Trypsin activation"
        },
        {
            "endOffset": 13783,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Epsilon toxin (Etx), a \u03b2-pore-forming toxin, is produced by C. perfringens strains that belong to toxinotypes B and D and plays a key role in the pathogenesis of enterotoxemia, a severe gastro-intestinal disease of ruminants that causes severe economic losses to farmers worldwide.",
            "startOffset": 13502,
            "title": "Introduction"
        },
        {
            "endOffset": 22230,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "The experiment was terminated at 24 h post challenge.",
            "startOffset": 22177,
            "title": "Toxicity of trypsin activated Y30A-Y196A in mice"
        },
        {
            "endOffset": 22651,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "The onset of neurological symptoms marked a humane endpoint and animals showing neurological symptoms were euthanized.",
            "startOffset": 22533,
            "title": "Toxicity of trypsin activated Y30A-Y196A in mice"
        },
        {
            "endOffset": 14803,
            "parents": [],
            "refoffsets": {
                "bib0030": {
                    "endOffset": 14802,
                    "startOffset": 14797
                },
                "bib0035": {
                    "endOffset": 14802,
                    "startOffset": 14797
                }
            },
            "secId": "sec0005",
            "sentence": "While infection of the central nervous system results in neurological disorders, the fatal effects on the organs often lead to sudden death [6,7].",
            "startOffset": 14657,
            "title": "Introduction"
        },
        {
            "endOffset": 22010,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "Control animals received 100 \u03bcl PBS each.",
            "startOffset": 21969,
            "title": "Toxicity of trypsin activated Y30A-Y196A in mice"
        },
        {
            "endOffset": 30725,
            "parents": [],
            "refoffsets": {
                "bib0050": {
                    "endOffset": 30673,
                    "startOffset": 30669
                },
                "bib0100": {
                    "endOffset": 30655,
                    "startOffset": 30651
                }
            },
            "secId": "sec0085",
            "sentence": "In previous studies trypsin activated Etx has been shown to have a LD50 dose ranging from 70 ng/kg [20] to 320 ng/kg [10] when administered by the intravenous route to mice.",
            "startOffset": 30552,
            "title": "Discussion"
        },
        {
            "endOffset": 16470,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Therefore, this study aimed to determine the potential of a site-directed mutant of Etx with mutations Y30A and Y196A combined, termed Y30A-Y196A, to be exploited as a recombinant vaccine against enterotoxemia.",
            "startOffset": 16260,
            "title": "Introduction"
        },
        {
            "endOffset": 32811,
            "parents": [],
            "secId": "sec0090",
            "sentence": "MBB and CAH carried out most of the experiments and drafted the manuscript.",
            "startOffset": 32736,
            "title": "Authors\u2019 contributions"
        },
        {
            "endOffset": 31324,
            "parents": [],
            "refoffsets": {
                "bib0115": {
                    "endOffset": 31323,
                    "startOffset": 31319
                }
            },
            "secId": "sec0085",
            "sentence": "This figure correlates well with the consensus LD50 value of 100 ng/kg after intravenous administration of activated Etx to mice [23].",
            "startOffset": 31190,
            "title": "Discussion"
        },
        {
            "endOffset": 15114,
            "parents": [],
            "refoffsets": {
                "bib0040": {
                    "endOffset": 15054,
                    "startOffset": 15051
                },
                "bib0045": {
                    "endOffset": 15113,
                    "startOffset": 15107
                },
                "bib0050": {
                    "endOffset": 15113,
                    "startOffset": 15107
                }
            },
            "secId": "sec0005",
            "sentence": "Toxin activation typically occurs in the gut either by digestive proteases of the host, such as trypsin and chymotrypsin [8], or by \u03bb-protease produced by C. perfringens itself [9,10].",
            "startOffset": 14930,
            "title": "Introduction"
        },
        {
            "endOffset": 23166,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "In an attempt to identify an Etx variant with markedly reduced toxicity relative to wild type toxin that could be considered as a recombinant vaccine candidate, we combined mutations Y30A and Y196A, generating the double tyrosine mutant, termed Y30A-Y196A (Fig. 1A).",
            "startOffset": 22900,
            "title": "Identification of recombinant Y30A-Y196A as a vaccine candidate"
        },
        {
            "endOffset": 27610,
            "parents": [],
            "secId": "sec0085",
            "sentence": "This study was conducted to determine the potential of the site-directed Etx mutant Y30A-Y196A to be exploited as a recombinant vaccine against enterotoxemia.",
            "startOffset": 27452,
            "title": "Discussion"
        },
        {
            "endOffset": 29408,
            "parents": [],
            "refoffsets": {
                "bib0070": {
                    "endOffset": 29253,
                    "startOffset": 29249
                }
            },
            "secId": "sec0085",
            "sentence": "Single mutants Y30A and Y196A have previously been shown to have 27-fold and 10-fold reduction in cytotoxicity toward MDCK.2 cells relative to Etx-H149A (with an average CT50 of 12 nM), respectively [14], which corresponds to 93-fold and 34-fold reduction in cytotoxic activity relative to wild type Etx (with an average CT50 value of 3.47 nM), respectively.",
            "startOffset": 29050,
            "title": "Discussion"
        },
        {
            "endOffset": 25084,
            "parents": [
                {
                    "id": "sec0055",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "Etx mutant H106P showed similar binding to wild type toxin in both cell lines (Fig. 3).",
            "startOffset": 24997,
            "title": "Binding of Y30A-Y196A prototoxin to MDCK.2 and ACHN cells"
        },
        {
            "endOffset": 30410,
            "parents": [],
            "secId": "sec0085",
            "sentence": "There is a scarcity of data on the LD50 dose of Etx in the literature when given by the intraperitoneal route to mice.",
            "startOffset": 30292,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X14004605",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "m.bokori-brown@exeter.ac.uk",
                "first": "Monika",
                "initial": "M.",
                "last": "Bokori-Brown"
            },
            {
                "email": null,
                "first": "Charlotte A.",
                "initial": "C.A.",
                "last": "Hall"
            },
            {
                "email": null,
                "first": "Charlotte",
                "initial": "C.",
                "last": "Vance"
            },
            {
                "email": null,
                "first": "S\u00e9rgio P.",
                "initial": "S.P.",
                "last": "Fernandes da Costa"
            },
            {
                "email": null,
                "first": "Christos G.",
                "initial": "C.G.",
                "last": "Savva"
            },
            {
                "email": null,
                "first": "Claire E.",
                "initial": "C.E.",
                "last": "Naylor"
            },
            {
                "email": null,
                "first": "Ambrose R.",
                "initial": "A.R.",
                "last": "Cole"
            },
            {
                "email": null,
                "first": "Ajit K.",
                "initial": "A.K.",
                "last": "Basak"
            },
            {
                "email": null,
                "first": "David S.",
                "initial": "D.S.",
                "last": "Moss"
            },
            {
                "email": null,
                "first": "Richard W.",
                "initial": "R.W.",
                "last": "Titball"
            }
        ],
        "doi": "10.1016/j.vaccine.2014.03.079",
        "firstpage": "2682",
        "issn": "0264410X",
        "keywords": [
            "Clostridium perfringens",
            "Enterotoxemia",
            "Epsilon toxin pore-forming toxin",
            "Recombinant vaccine"
        ],
        "lastpage": "2687",
        "openaccess": "Full",
        "pub_year": 2014,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia"
    }
}